Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial
Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial
复制标题
DOI:
10.1136/bmj.325.7367.746
复制
发表时间:
2002-10-05
影响因子:
105.7
通讯作者:
Wright, F
中科院分区:
文献类型:
--
作者:
Amiel, S;Beveridge, S;Wright, F
Objectives To evaluate whether a course teaching flexible intensive insulin treatment combining dietary freedom and insulin adjustment can improve both glycaemic control and quality of life in type 1 diabetes.Design Randomised design with participants either attending training immediately (immediate DAFNE) or acting as waiting list controls and attending "delayed DAFNE" training 6 months later.Setting Secondary care diabetes clinics in three English health districts.Participants 169 adults with type 1 diabetes and moderate or poor glycaemic control.Main outcome measures Glycated haemoglobin (HbA(1c), severe hypoglycaemia, impact of diabetes on quality of life (ADDQoL).Results At 6 months, HbA(1c) was significantly better in immediate DAFNE patients (mean 8.4%) than in delayed DAFNE patients (9.4%) (t-6.1, P < 0.0001). The impact of diabetes on dietary freedom was significantly improved in immediate DAFNE patients compared with delayed DAFNE patients (t= - 5.4, P < 0.0001), as was the impact of diabetes on overall quality of life (t=2.9, P < 0.01). General wellbeing and treatment satisfaction were also significantly improved, but severe hypoglycaemia, weight, and lipids remained unchanged. Improvements in "present quality of life" did not reach significance at 6 months but were significant by 1 year.Conclusion Skills training promoting dietary freedom improved quality of life and glycaemic control in people with type 1 diabetes without worsening severe hypoglycaemia or cardiovascular risk. This approach has the potential to enable more people to adopt intensive insulin treatment and is worthy of further investigation.